↓ Skip to main content

Cochrane Database of Systematic Reviews

Betahistine for Ménière's disease or syndrome

Overview of attention for article published in Cochrane database of systematic reviews, January 2001
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

policy
2 policy sources
twitter
16 X users
wikipedia
6 Wikipedia pages

Citations

dimensions_citation
208 Dimensions

Readers on

mendeley
142 Mendeley
Title
Betahistine for Ménière's disease or syndrome
Published in
Cochrane database of systematic reviews, January 2001
DOI 10.1002/14651858.cd001873
Pubmed ID
Authors

Adrian James, Martin J Burton

Abstract

Menière's disease is characterised by attacks of hearing loss, tinnitus and disabling vertigo. Betahistine is used by many people to reduce the frequency and severity of these attacks but there is conflicting evidence relating to its effects. The objective of this review was to assess the effects of betahistine in people with Menière's disease. We searched the Cochrane Controlled Trials Register (The Cochrane Library issue 4,1999), MEDLINE (January 1966 to December 1999), EMBASE (January 1985 to December 1999) and Index Medicus (1962 to 1966). We checked reference lists of articles and contacted pharmaceutical companies for further studies. Randomised controlled studies of betahistine versus placebo in Menière's disease. Two reviewers independently assessed trial quality and extracted data. Study authors were contacted for further information. Six trials involving 162 patients were included. No trial met the highest quality standard set by the review because of inadequate diagnostic criteria or methods, and none assessed the effect of betahistine on vertigo adequately. Most trials suggested a reduction of vertigo with betahistine and some suggested a reduction in tinnitus but all these effects may have been caused by bias in the methods. One trial with good methods showed no effect of betahistine on tinnitus compared with placebo in 35 patients. None of the trials showed any effect of betahistine on hearing loss. No adverse effects were found with betahistine. There is insufficient evidence to say whether betahistine has any effect on Menière's disease.

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 142 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 1%
United Kingdom 1 <1%
Unknown 139 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 18%
Student > Bachelor 23 16%
Student > Postgraduate 11 8%
Researcher 9 6%
Professor 8 6%
Other 28 20%
Unknown 37 26%
Readers by discipline Count As %
Medicine and Dentistry 64 45%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Nursing and Health Professions 8 6%
Neuroscience 5 4%
Biochemistry, Genetics and Molecular Biology 3 2%
Other 14 10%
Unknown 38 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2024.
All research outputs
#2,057,209
of 25,758,695 outputs
Outputs from Cochrane database of systematic reviews
#4,325
of 13,137 outputs
Outputs of similar age
#2,980
of 114,840 outputs
Outputs of similar age from Cochrane database of systematic reviews
#1
of 43 outputs
Altmetric has tracked 25,758,695 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,137 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 114,840 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.